Social Media Ideas for Pltr

Palantir: U.S. Commercial Segment Drives The Next Bull Leg

Palantir Remains Our Top Tech Pick Of The 2020s

Palantir: Great Business, No Margin Of Safety

Is Palantir Stock a Buy Right Now?

The data-aggregating company has a bright future, but it's trading at a premium valuation.

Palantir: Staying Bullish At Record Highs As Q3 Approaches

Prediction: This Will Be Palantir's Stock Price 1 Year From Now (Hint: It's a Bigger Move Than You Think)

Palantir stock is flat on the year, but meaningful upside could be on the horizon.

Palantir Hits Our Price Target - We Move To Distribute Rating (Downgrade)

Prediction: This Will Be Palantir’s Stock Price in a Year (Hint: It Implies Upside)

Palantir is an excellent company, but it’s also an expensive stock.

Palantir Stock: Buy, Sell, or Hold?

Palantir's growth and profitability are exceptional, but its valuation leaves little room for disappointment. Here's the metric that helps explain both sides of the investment case...

Palantir Is Out Of Catalysts (Rating Downgrade)

Better Buy: Palantir Stock vs. Microsoft Stock

The rising effectiveness of artificial intelligence is creating an increasing demand for enterprise implementation.

Is Palantir a Millionaire-Maker Stock After Its Rally?

The stock has jumped more than 60% over three months.

Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therap...

Why Is Palantir Stock Down Today?

Palantir stock is falling on Sept. 2, 2026, even after the company landed a new U.S. Army TITAN contract and hired AIG's Peter Zaffino as its global head of financial services.

Could $20,000 Invested in Palantir Help You Retire a Millionaire?

The stock has offered investors a major win in recent years.

Palantir leads August tech rally as sector gains over 6%

Where Will Palantir Stock Be in 5 Years?

The next half-decade is full of opportunities and uncertainty.

Is It Too Late to Buy Palantir Stock?

Palantir stock is up more than 1,000% in the last three years.

Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therap...

Palantir: I Couldn't Have Been More Wrong, I See The Light Now - Buy (Rating Upgrade)

Why Nebius Is Getting The Better End Of The Deal From Palantir

Palantir Is Not C3.ai, But C3.ai Wrote Its Watch List - Downgrade Palantir To Hold, Sell C3.ai

History Says This Will Happen to Palantir Stock by 2028

The AI data analytics company's stock is extremely pricey.

Palantir's Stock Is Up Over 50% Since Reporting Earnings. Is It Heading for a New All-Time High?

Investors are bullish on Palantir's stock due to not only the company's strong growth but also a convincing vision from CEO Alex Karp.